Final report of a phase II study of 5-azacitidine and vorinostat in patients (pts) with newly diagnosed myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML) not eligible for clinical trials because poor performance and presence of other comorbidities Meeting Abstract
| Authors: | Garcia-Manero, G.; Estey, E. H.; Jabbour, E.; Borthakur, G.; Kadia, T.; Naqvi, K.; Levine, R. L.; Estrov, Z.; Quintas-Cardama, A.; Konopleva, M.; Faderl, S.; Tanaka, M.; Yang, H.; Ravandi, F.; Wierda, W. G.; Cortes, J. E.; Boone, P. A.; Kantarjian, H. M. |
| Abstract Title: | Final report of a phase II study of 5-azacitidine and vorinostat in patients (pts) with newly diagnosed myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML) not eligible for clinical trials because poor performance and presence of other comorbidities |
| Meeting Title: | 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis |
| Journal Title: | Blood |
| Volume: | 118 |
| Issue: | 21 |
| Meeting Dates: | 2011 Dec 10-13 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2011-11-01 |
| Start Page: | 279 |
| Language: | English |
| ACCESSION: | WOS:000299597100609 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V118.21.608.608 |
| Notes: | --- - Meeting Abstract: 608 - 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis - DEC 10-13, 2011 - San Diego, CA - "Source: Wos" |
